Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy.
Carozzi FM, Tornesello ML, Burroni E, Loquercio G, Carillo G, Angeloni C, Scalisi A, Macis R, Chini F, Buonaguro FM, Giorgi Rossi P; HPV Prevalence Italian Working Group. Carozzi FM, et al. Among authors: burroni e. Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2389-400. doi: 10.1158/1055-9965.EPI-10-0131. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20826836
Human papilloma virus genotyping for the cross-sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more.
Del Mistro A, Adcock R, Carozzi F, Gillio-Tos A, De Marco L, Girlando S, Rizzolo R, Frayle H, Trevisan M, Sani C, Burroni E, Giorgi Rossi P, Cuzick J, Ronco G; New Technologies for Cervical CancerWorking Group. Del Mistro A, et al. Among authors: burroni e. Int J Cancer. 2018 Jul 15;143(2):333-342. doi: 10.1002/ijc.31326. Epub 2018 Mar 9. Int J Cancer. 2018. PMID: 29453769 Free PMC article. Clinical Trial.
Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence.
Carozzi F, De Marco L, Gillio-Tos A, Del Mistro A, Girlando S, Baboci L, Trevisan M, Burroni E, Grasso S, Giorgi Rossi P, Ronco G; NTCC Working Group. Carozzi F, et al. Among authors: burroni e. J Clin Virol. 2014 Jul;60(3):257-63. doi: 10.1016/j.jcv.2014.04.009. Epub 2014 Apr 18. J Clin Virol. 2014. PMID: 24815381
Effectiveness of HPV vaccination in women reaching screening age in Italy.
Carozzi FM, Ocello C, Burroni E, Faust H, Zappa M, Paci E, Iossa A, Bonanni P, Confortini M, Sani C. Carozzi FM, et al. Among authors: burroni e. J Clin Virol. 2016 Nov;84:74-81. doi: 10.1016/j.jcv.2016.09.011. Epub 2016 Oct 3. J Clin Virol. 2016. PMID: 27728850 Clinical Trial.
Distribution of high and low risk HPV types by cytological status: a population based study from Italy.
Giorgi Rossi P, Chini F, Bisanzi S, Burroni E, Carillo G, Lattanzi A, Angeloni C, Scalisi A, Macis R, Pini MT, Capparucci P, Guasticchi G, Carozzi FM; Prevalence Italian Working Group.HPV. Giorgi Rossi P, et al. Among authors: burroni e. Infect Agent Cancer. 2011 Jan 20;6:2. doi: 10.1186/1750-9378-6-2. Infect Agent Cancer. 2011. PMID: 21247508 Free PMC article.
Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening.
Burroni E, Bonanni P, Sani C, Lastrucci V, Carozzi F; Hpv ScreeVacc Working Group; Iossa A, Andersson KL, Brandigi L, Di Pierro C, Confortini M, Levi M, Boccalini S, Indiani L, Sala A, Tanini T, Bechini A, Azzari C. Burroni E, et al. J Med Virol. 2015 Mar;87(3):508-15. doi: 10.1002/jmv.24085. Epub 2014 Nov 21. J Med Virol. 2015. PMID: 25418873
27 results